Monarch Capital Management’s Amgen AMGN Stock Holding History

Monarch Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Sell	730 -30	-4%	-$10.3K	0.06%	122
2026 Q1	$267K	Hold	760	–	–	0.07%	118
2025 Q4	$249K	Hold	760	–	–	0.06%	117
2025 Q3	$214K	Hold	760	–	–	0.05%	120
2025 Q2	$212K	Hold	760	–	–	0.06%	114
2025 Q1	$237K	Buy	+760	New	+$224K	0.07%	109
2024 Q4	–	Sell	-760	Closed	-$245K	–	115
2024 Q3	$245K	Buy	760 +50	+7%	+$16.4K	0.07%	111
2024 Q2	$222K	Hold	710	–	–	0.07%	110
2024 Q1	$202K	Hold	710	–	–	0.06%	115
2023 Q4	$204K	Buy	+710	New	+$193K	0.06%	110

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Monarch Capital Management's AMGN Position: Q2 2026 in Review

Monarch Capital Management reduced its Amgen (AMGN) stake by 3.9% in Q2 2026, selling an estimated $10.3K and leaving 730 shares worth $264K. The position accounts for 0.06% of the portfolio, ranked #122.

Monarch Capital Management first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $267K in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Monarch Capital Management held 730 shares of Amgen worth $264K as of Q2 2026.
Monarch Capital Management sold 30 Amgen shares in Q2 2026, an estimated $10.3K.
Amgen made up 0.06% of Monarch Capital Management's portfolio in Q2 2026, its #122 holding.
Monarch Capital Management first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
Monarch Capital Management's Amgen position peaked at $267K in Q1 2026.
1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.